key: cord-0854400-82aln6ao
authors: Rooney, Scott; Webster, Amy; Paul, Lorna
title: Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome–Related Coronavirus Infection: Implications for COVID-19 Rehabilitation
date: 2020-07-31
journal: Phys Ther
DOI: 10.1093/ptj/pzaa129
sha: 245525a71bd5bc5e42bf2d53f2dafc079633d36e
doc_id: 854400
cord_uid: 82aln6ao

OBJECTIVES: 1) Compare physical function and fitness outcomes in people infected with SARS-CoV to healthy controls; 2) quantify the recovery of physical function and fitness following SARS-CoV infection; 3) determine the effects of exercise following SARS-CoV infection. METHODS: Four databases (CINAHL, MEDLINE, ProQuest, and Web of Science Core Collections) were searched in April 2020 using keywords relating to SARS-CoV, physical function, fitness, and exercise. Observational studies or randomised controlled trials were included if they involved people following SARS-CoV infection and either assessed the change or recovery in physical function/fitness or evaluated the effects exercise postinfection. RESULTS: 10 articles were included in this review. Evidence from nine articles demonstrated that SARS-CoV patients had reduced levels of physical function and fitness postinfection in comparison to healthy controls. Furthermore, patients demonstrated incomplete recovery of physical function, with some experiencing residual impairments 1 to 2 years postinfection. Evidence from one randomised controlled trial found that a combined aerobic and resistance training intervention significantly improved physical function and fitness postinfection in comparison to a control group. CONCLUSIONS: Physical function and fitness are impaired following SARS-CoV infection, and impairments may persist up to 1 to 2 years postinfection. Researchers and clinicians can use these findings to understand the potential impairments and rehabilitation needs of people recovering from the current COVID-19 outbreak. While one study demonstrated that exercise can improve physical function and fitness postinfection, further research is required to determine the effectiveness of exercise in people recovering from similar infections (eg, COVID-19). IMPACT STATEMENT: Considering the similarities in pathology and clinical presentation of SARS-CoV and COVID-19, it is likely that COVID-19 patients will present with similar impairments to physical function. Accordingly, research is required to measure the extent of functional impairments in COVID-19 cohorts. In addition, research should evaluate whether rehabilitation interventions such as exercise can promote postinfection recovery.

In December 2019, the first case of novel coronavirus 2019 (COVID- 19) was confirmed in Wuhan, Hubei Province, China; 1 since then, over 11 .3 million cases have been confirmed globally (as of July 6 th 2020), with the World Health Organisation declaring the current outbreak a pandemic. 2 The majority (80%) of people infected with COVID-19 present with mild-moderate disease characterised by a fever, persistent cough, and dyspnoea. 3 However, more severe disease is experienced by 20% of people 4particularly in those over 65 years old and with comorbidities such as cardiovascular disease, diabetes, and chronic respiratory disease. 5, 6 It is estimated that around 30% of people infected with COVID-19 will require hospitalisation, 7 and of those hospitalised, 20% will be admitted to an Intensive Care Unit (ICU). 3 During periods of critical illness and hospitalisation, it is common for people to experience a loss of physical function, 8 which can be characterised by the development of new or worsening of existing impairments. 9 Acquired changes to physical function during periods of hospitalisation and critical illness are more commonly experienced by those with more severe illness or existing comorbidities, 8 and often lead to mobility disability and restrictions in activities of daily living. 10 This decrease in physical functioning is thought to be attributed to prolonged periods of immobility, during which time people experience deconditioning (ie, a reduction in physical fitness outcomes such as muscle strength or aerobic capacity), 11 or develop critical illness polyneuropathy and myopathy leading to impaired neuromuscular function. 12 Furthermore, in more severe cases, Acute Respiratory Distress Syndrome (ARDS)which accounts for over 30% of COVID-19 related ICU admissions 3also leads to deconditioning and long-term impairments in physical function. 13 Therefore, considering the rising number of COVID-19 cases and the significant proportion of people that are hospitalised and require ICU care for management of the infection, it is likely that many people will require rehabilitation to promote recovery postinfection. 14 Accordingly, it is important to understand the effect of COVID-19 on physical function and fitness in order to inform the design and assessment of rehabilitation interventions such as exercise, which has been demonstrated to improve physical function following critical illness by a previous systematic review. 15 

While there are currently no studies reporting the effect of COVID-19 on physical function and fitness, the importance of these outcomes to rehabilitation could be identified by reviewing the impact of the Severe Acute Respiratory Syndrome-related Coronavirus (SARS-CoV) on physical function and fitness. SARS-CoV is a type of coronavirus which presents with similar symptoms to COVID-19 and caused a similar global outbreak of disease in 2003. 16 While the reported cases of SARS-CoV were significantly lower than the current COVID-19 pandemic, 17 a similar proportion of people infected with SARS-CoV were hospitalised and admitted to ICU; 18 therefore, postinfection changes and recovery in physical function and fitness in people with COVID-19 may follow a similar pattern to those infected with SARS-CoV. Accordingly, this review aims to: 1) compare physical function and fitness outcomes in people infected with SARS-CoV to healthy controls; 2) quantify the recovery of physical function and fitness following SARS-CoV infection; 3) determine the effects of exercise on people following SARS-CoV infection.

[H1] Methods

A systematic review protocol was registered with the PROSPERO database in April 2020 (ID#: CRD42020182575 

Both randomised controlled trials and observational studies (with either a cross-sectional or prospective design) that included adults who had been infected with SARS-CoV were eligible for this review. Furthermore, studies were also required to meet one of the following criteria: 1) assess physical function or physical fitness in people following SARS-CoV infection in comparison to a healthy control group using an objective measurement; 2) longitudinally assess physical function or physical fitness in people following SARS-CoV infection using an objective measurement; 3) evaluate the effects of an exercise intervention following SARS-CoV infection either as a standalone intervention or as part of a rehabilitation programme. Only full-text articles published in English were included in this review; grey literature and conference abstracts were excluded.

After removing duplicate articles, search results were exported to Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia). The title and abstracts of all articles were then screened against the eligibility criteria by one reviewer (SR). Subsequently, two reviewers (SR, AW) independently screened full texts of all remaining articles for eligibility, and disagreements were resolved through consensus in consultation with a third reviewer (LP) if required.

Data extraction was completed independently by one reviewer (SR) using a standardised data extraction form. Data that was extracted from all studies included: study details (author, year of publication, study design, location of study) and participant demographics (sample size, age, gender, time since infection, duration of hospitalisation, comorbidities). Furthermore, either the outcome measures used to assess physical function/fitness and time-points of assessment, or details of the exercise intervention (type, duration, frequency, intensity, control group) and effect were also extracted.

Methodological quality of included studies was assessed by two reviewers (SR, AW) using either the PEDro scale for randomised controlled trials 19 or the NIH quality assessment tool for observational cohort and cross-sectional studies. 20 Quality assessment was completed independently, and any discrepancies between reviewers were resolved through consensus in consultation with a third reviewer (LP) if required.

No studies were excluded based on the result of the quality assessment.

The results of the included studies were analysed through separate narrative syntheses corresponding to the aims of this systematic review.

Firstly, descriptive values of physical function and fitness outcomes were compared to normative control data reported in each study in order to determine the difference in physical function/fitness following SARS-CoV infection. These results were compared between studies which include the same outcome measures to determine consistency of the results. Secondly, longitudinal descriptive data was synthesised to determine the extent of recovery in physical function and fitness at various time-points following infection. The mean/median change in physical function/fitness over time (either in comparison to control values or baseline data) determined the rate and magnitude of recovery postinfection.

Lastly, for randomised controlled trials, individual study estimates of treatment effects (size and direction) were presented in order to determine the effects of exercise postinfection.

The funders played no role in the design, conduct, or reporting of this study.

After removing duplicates, the title and abstracts of 377 articles were screened against the eligibility criteria and 363 were excluded primarily as the studies did not included people infected with SARS-CoV (n = 161) or the articles were grey literature (n=105). The full-texts of the remaining 14 articles were then screened for eligibility, and four were excluded as two articles which described observational studies did not include a measure of physical function or fitness, one article included a single measure of physical function but did not compare values to healthy controls, and one article was a conference abstract. Accordingly, 10 articles 21-30 were included in this systematic review ( Fig. 1 ).

Of the included articles, six reported the results of cohort studies investigating longitudinal changes in physical function (Tab. 1), 22,23,26,28-30 three described the results of cross-sectional studies investigating the difference in physical function and fitness in comparison to healthy controls (Tab. 1), 21, 25, 27 and one reported the results of a randomised controlled trial investigating the effects of an exercise intervention following SARS-CoV infection (Tab. 2). 24 The results of one cohort study were reported across four articles-Hui et al, 22 Hui et al, 23 Taiwan, n = 1 27 ), with only one study conducted outside of Asia (Canada, n = 1). 28

The overall methodological quality of the included articles is described in Tables 2 and 3 , and a detailed description of each item response is provided in Supplementary Tables 2 and 3 . The total number of items adequately addressed on the NIH quality assessment tool ranged from 6 27 22 Most studies had clearly defined and consistent eligibility criteria, recruited at least 50% of the eligible population, and used valid and reliable outcome measures to quantify physical function/fitness. However, only five studies controlled for confounding variables such as age, 22, 23, 25, 26, 30 and only two studies had a loss to follow-up of less than 20%. 22, 28 The randomised controlled trial by Lau et al 24 scored nine on the PEDro scale; due to the nature of the intervention, neither the participants nor therapists were blinded to treatment allocation.

Across the observational studies, a total of 516 people infected with SARS-CoV were included with sample sizes ranging from 13 to 171.

Participants were included in each study at various times postinfection, with studies including participants at 3 months post-infection onset (ie, 3 months since the initial presentation of symptoms related to the infection), 22 The sample size of the randomised controlled trial by Lau et al 24 

All of the observational studies included in this review compared measures of physical function or fitness in people with SARS-CoV to healthy controls (Table 1) . Of these studies, four measured physical function, 22 

Of the cohort studies measuring recovery postinfection, all measured changes in physical function using the 6MWT. 22 23 ,29 also reported that no significant change in 6MWT distance was found between 3 and 12 months post-infection onset, indicating that there was minimal long-term recovery of physical function postinfection. Furthermore, in the sub-group analysis of the cohort initially described by Hui et al. 22 Ngai et al 30 also found that no change in 6MWT was found between 3 to 24 months post-infection onset.

The randomised controlled trial by Lau et al 24 minutes of aerobic exercise at 60% to 70% of predicted maximal heart rate, and resistance training targeting the upper and lower limbs.

Participants in the control group received advice about general exercise and weekly telephone conversations with a physical therapist. 

The evidence presented in this review highlights the long-term impact of SARS-CoV infection on physical function and fitness. Evidence from a small number of studies demonstrates that, following SARS-CoV infection, patients have reduced levels of physical function and fitness in comparison to healthy controls. Furthermore, while an increase in physical function is noted within the first 6 months following infection onset, recovery is incomplete and people with SARS-CoV may experience residual impairments in physical function 1-2 years after the infection.

Therefore, this highlights the need for rehabilitation interventions to promote physical recovery of people following SARS infection. Evidence from one randomised controlled trial suggests that exercise may promote recovery in physical function and fitness in people infected with SARS-CoV. 24 However, further evidence is required to determine the effectiveness of rehabilitation interventions, such as exercise, in promoting recovery postinfectionparticularly during the current outbreak of COVID-19 in which similar patterns of impairments and recovery in physical function may be experienced.

The mechanisms leading to impaired physical function following SARS-CoV infection are likely multifactorial and arise as a consequence of the infection, prolonged hospitalisation, and/or immobility. 31 For example, during periods of immobility due to critical illness, around 25% of patients develop significant muscle weaknessparticularly of the lower limb muscle groups involved in functional mobility. 32 This acquired

weakness may be attributed to a decrease in muscle cross-sectional area and muscle fibre size, 33, 34 or a reduction in type II muscle fibres. 35 In addition, up to 50% of people admitted to ICU may develop critical illness myopathy or neuropathy leading to a reduction in motor unit recruitment and force generating capacity of the muscle. 12 Alongside changes in muscle function, lower levels of aerobic capacity are associated with reduced physical function and independence during activities of daily living. 36 As identified through this review, people infected with SARS-CoV demonstrate decreased VO 2max independent of pulmonary and ventilatory function; thus, deconditioning and decreased levels of cardiorespiratory fitness may also account for the reductions in physical function postinfection. Furthermore, post-viral fatigue, which was reported in 40% of people following SARS-CoV infection, 37 may also contribute to reduced physical function due to increased perception of effort during functional tasks. 38 Importantly, the proposed mechanisms contributing to impaired physical function are not unique to SARS-CoV infection and may be experienced by all causes of critical illness and hospitalisation. 39 These mechanisms may also cause impairments to physical function in people infected with COVID-19particularly considering the number of people currently hospitalised and admitted to ICU with COVID-19. 3, 7 Accordingly research is required to measure physical function in people following COVID-19 infection to determine whether similar impairments are experienced postinfection, and to quantify the prevalence and severity of any changes to physical function.

As highlighted by the studies included in this review, recovery of physical function following SARS-CoV is incomplete with impairments persisting up to 1 to 2 years post-infection onset. Greater levels of impairment in physical function after 12 months were found in those patients who required mechanical ventilation during hospitalisation, 26 indicating that the severity of infection may be associated with poorer recovery postinfection. Promoting recovery of physical function in people with SARS-CoV should be a key target of postinfection management, as longterm physical function and quality of life were shown to be positively correlated in people with SARS-CoV, indicating that lower levels of physical function postinfection are associated with poorer quality of life. 23, 26 In addition, two studies which found incomplete recovery of physical function reported that only 80-83% of people had returned to work 12-months following infection onset. 28,30 Accordingly, the evidence

presented in this review highlights the need for rehabilitation to promote recovery of physical function following SARS infectionparticularly in those hospitalised with severe infections.

In order to design effective rehabilitation strategies, the selection of intervention type and dose must be specific to key functional impairments.

As physical function and fitness were demonstrated to be impaired following SARS-CoV infection, exercisewhich aims to improve or maintain aspects of physical fitness and function 40may be an appropriate rehabilitation intervention to address these impairments. Indeed, evidence from one study found that a combined aerobic and resistance training intervention improved 6MWT distance and VO 2max by approximately 13% and 3% within the first 2-months post hospital discharge following SARS-CoV infection. 24 This evidence is in line with findings from a Cochrane review where a small number of studies reported that exercise may improve physical function following critical illness. 15 However, despite the potential beneficial effect of exercise, there is a lack of evidence to support its use for people with SARS-CoV infection as only one study evaluating the effects of exercise was identified by this review. In addition, the safety of exercise following SARS-CoV is unclear, as this study did not report whether any adverse events occurred.

Due to the large cohort of COVID-19 survivors, and considering the physical complications of hospitalisation and ICU admission, it is anticipated that there will be a large demand for rehabilitation to promote postinfection recovery. 14 

Evidence from this review highlights that physical function and fitness are reduced in people following SARS-CoV infection. Furthermore, recovery of physical function is incomplete with impairments persisting 1 to 2 years postinfection. Due to the similarities in pathology and the significant number of people admitted to hospital and ICU, it is likely that people with COVID-19 will experience similar impairments to physical function and fitness. Therefore, rehabilitation interventions are required to promote recovery postinfection. While exercise may improve physical function postinfection, only one study has evaluated the effects of exercise in a SARS-CoV population. Accordingly, research is required to understand the effects of COVID-19 on physical function and fitness, and determine whether exercise can promote postinfection recovery. 

U N C O R R E C T E D M

The protocol for this systematic review was registered with PROSPERO (CRD42020182575).

The authors completed the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported no conflicts of interest. 

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

World Health Organisation. Coronavirus disease (COVID-19): Situation report -168

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)

Estimates of the severity of coronavirus disease 2019: A model-based analysis

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A singlecentered, retrospective, observational study

European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK -eighth update

European Centre for Disease Prevention and Control

Post-intensive care syndrome: An overview

Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders' conference

Disability among elderly survivors of mechanical ventilation

Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers

Neuromuscular dysfunction acquired in critical illness: A systematic review

Functional disability 5 years after acute respiratory distress syndrome

Rehabilitation following critical illness in people with COVID-19 infection

Exercise rehabilitation following intensive care unit discharge for recovery from critical illness

Coronavirus as a possible cause of severe acute respiratory syndrome

World Health Organisation. Summary of probable SARS cases with onset of illness from 1

Severe acute respiratory distress syndrome (SARS): A critical care perspective

Reliability of the PEDro scale for rating quality of randomized controlled trials

Quality assessment tool for observational cohort and cross-sectional studies

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors

The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors

A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome

Acute skeletal muscle wasting in critical illness

Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function

The effect of bed rest and potential of prehabilitation on patients in the intensive care unit

Aerobic reserve and physical functional performance in older adults

Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up

Disability and chronic fatigue syndrome: A focus on function

ICU-acquired weakness and recovery from critical illness

Physical activity, exercise, and physical fitness: Definitions and distinctions for health-related research

6MWT distance (m) 3 mo: 439.0 (SD = 89.1) 6 mo: 460.1 (SD = 102.8) (vs 3 mo

Hong Kong. 6MWT = 6-Minute Walk Test

GH = general health subscale

HR max = maximum heart rate

MH = mental health subscale

PF = physical function subscale; RE = role emotional subscale

SF = social functioning subscale; SF-36 = Medical Outcomes Survey Short-Form 36 questionnaire; V = vitality subscale